Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis

The 2016 Zika virus (ZIKV) epidemic has largely subsided, but a key question remains. How did ZIKV evolve to become a virulent human pathogen compared to the virus of its original discovery? What specific virologic and pathologic changes contributed to increased pathogenicity in humans? Phylogenetic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashkan Roozitalab, Chenyu Zhang, Jiantao Zhang, Ge Li, Chengyu Yang, Wangheng Hou, Qiyi Tang, Richard Y. Zhao
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/7/716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849732967033733120
author Ashkan Roozitalab
Chenyu Zhang
Jiantao Zhang
Ge Li
Chengyu Yang
Wangheng Hou
Qiyi Tang
Richard Y. Zhao
author_facet Ashkan Roozitalab
Chenyu Zhang
Jiantao Zhang
Ge Li
Chengyu Yang
Wangheng Hou
Qiyi Tang
Richard Y. Zhao
author_sort Ashkan Roozitalab
collection DOAJ
description The 2016 Zika virus (ZIKV) epidemic has largely subsided, but a key question remains. How did ZIKV evolve to become a virulent human pathogen compared to the virus of its original discovery? What specific virologic and pathologic changes contributed to increased pathogenicity in humans? Phylogenetic studies have identified two genetically distinct ZIKV, the African and Asian lineages, which differ in their pathogenicity. Previous studies including ours suggest that the envelope (E) protein plays a key role in viral entry, immune activation, and neuropathogenesis. This study aimed to further elucidate virologic and pathogenic differences between these lineages by assessing their ability to bind and replicate in host cells, induce apoptotic cell death, trigger inflammatory responses, and influence human neural progenitor cell (hNPC)-derived neurosphere formation. We compared a historic African ZIKV strain (MR766) with an epidemic Brazilian strain (BR15) and evaluated the effects of the E protein inhibitor quercetin-3-β-O-D-glucoside (Q3G) and an E protein-neutralizing antibody (AbII). Our results revealed distinct virologic properties and that MR766 exhibited stronger inhibition of neurosphere formation due to enhanced viral binding to neuronal SH-SY5Y cells, while BR15 infection triggered a heightened pro-inflammatory cytokine response with reduced viral binding. Chimeric virus studies suggested that the E protein likely influences viral binding, replication efficiency, immune activation, and neuropathogenesis. Notably, Q3G exhibited antiviral activities against both MR766 and BR15, whereas AbII preferentially inhibited MR766. These findings highlight the virological differences between ancestral and epidemic viral strains, as well as the critical role of E protein in viral permissiveness, immune response, and neuropathogenesis, providing insights for developing targeted antiviral strategies.
format Article
id doaj-art-0de7492b29bb436da79b40f0ba6b02c5
institution DOAJ
issn 2076-0817
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj-art-0de7492b29bb436da79b40f0ba6b02c52025-08-20T03:08:10ZengMDPI AGPathogens2076-08172025-07-0114771610.3390/pathogens14070716Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and NeuropathogenesisAshkan Roozitalab0Chenyu Zhang1Jiantao Zhang2Ge Li3Chengyu Yang4Wangheng Hou5Qiyi Tang6Richard Y. Zhao7Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USAState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen 361102, ChinaDepartment of Microbiology, Howard University College of Medicine, Washington, DC 20059, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USAThe 2016 Zika virus (ZIKV) epidemic has largely subsided, but a key question remains. How did ZIKV evolve to become a virulent human pathogen compared to the virus of its original discovery? What specific virologic and pathologic changes contributed to increased pathogenicity in humans? Phylogenetic studies have identified two genetically distinct ZIKV, the African and Asian lineages, which differ in their pathogenicity. Previous studies including ours suggest that the envelope (E) protein plays a key role in viral entry, immune activation, and neuropathogenesis. This study aimed to further elucidate virologic and pathogenic differences between these lineages by assessing their ability to bind and replicate in host cells, induce apoptotic cell death, trigger inflammatory responses, and influence human neural progenitor cell (hNPC)-derived neurosphere formation. We compared a historic African ZIKV strain (MR766) with an epidemic Brazilian strain (BR15) and evaluated the effects of the E protein inhibitor quercetin-3-β-O-D-glucoside (Q3G) and an E protein-neutralizing antibody (AbII). Our results revealed distinct virologic properties and that MR766 exhibited stronger inhibition of neurosphere formation due to enhanced viral binding to neuronal SH-SY5Y cells, while BR15 infection triggered a heightened pro-inflammatory cytokine response with reduced viral binding. Chimeric virus studies suggested that the E protein likely influences viral binding, replication efficiency, immune activation, and neuropathogenesis. Notably, Q3G exhibited antiviral activities against both MR766 and BR15, whereas AbII preferentially inhibited MR766. These findings highlight the virological differences between ancestral and epidemic viral strains, as well as the critical role of E protein in viral permissiveness, immune response, and neuropathogenesis, providing insights for developing targeted antiviral strategies.https://www.mdpi.com/2076-0817/14/7/716Zika virus (ZIKV)envelope (E) proteinAfrican lineageAsian lineagehuman neural progenitor cell (hNPC)-derived neurosphereviral entry
spellingShingle Ashkan Roozitalab
Chenyu Zhang
Jiantao Zhang
Ge Li
Chengyu Yang
Wangheng Hou
Qiyi Tang
Richard Y. Zhao
Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
Pathogens
Zika virus (ZIKV)
envelope (E) protein
African lineage
Asian lineage
human neural progenitor cell (hNPC)-derived neurosphere
viral entry
title Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
title_full Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
title_fullStr Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
title_full_unstemmed Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
title_short Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis
title_sort distinct virologic properties of african and epidemic zika virus strains the role of the envelope protein in viral entry immune activation and neuropathogenesis
topic Zika virus (ZIKV)
envelope (E) protein
African lineage
Asian lineage
human neural progenitor cell (hNPC)-derived neurosphere
viral entry
url https://www.mdpi.com/2076-0817/14/7/716
work_keys_str_mv AT ashkanroozitalab distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT chenyuzhang distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT jiantaozhang distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT geli distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT chengyuyang distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT wanghenghou distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT qiyitang distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis
AT richardyzhao distinctvirologicpropertiesofafricanandepidemiczikavirusstrainstheroleoftheenvelopeproteininviralentryimmuneactivationandneuropathogenesis